Risk Factors of anemia in head and neck cancer patients undergoing chemotherapy with high-dose cisplatin
Cisplatin is well-known for its effectiveness treatment against cancer, as well as its toxicity to human tissues. Of several documented side effects, anemia was reported to have significant association with decreased quality of life. This study was conducted to investigate development of cisplatin-...
Main Authors: | Johan Kurnianda, Nugroho Wiyadi, Wahyu Wulaningsih |
---|---|
Format: | Article |
Language: | English |
Published: |
Faculty of Medicine Universitas Indonesia
2008-11-01
|
Series: | Medical Journal of Indonesia |
Online Access: | http://mji.ui.ac.id/journal/index.php/mji/article/view/328 |
Similar Items
-
ANALYSIS OF NACL-MANNITOL HYDRATION ON RENAL FUNCTION OF HEAD AND NECK CANCER PATIENTS RECEIVING HIGH-DOSE CISPLATIN CHEMOTHERAPY COMBINATION
by: Ekanita Desiani, et al.
Published: (2017-08-01) -
Induction chemotherapy with dose-modified docetaxel, cisplatin, and 5-fluorouracil in Asian patients with borderline resectable or unresectable head and neck cancer
by: Hung-Ming Wang, et al.
Published: (2017-03-01) -
Phenylbutyrate interferes with the Fanconi anemia and BRCA pathway and sensitizes head and neck cancer cells to cisplatin
by: Ljungman Mats, et al.
Published: (2008-03-01) -
Study of lotus seedpod extracts in combination with chemotherapy drug cisplatin in treatment of head and neck cancer
by: Tzu-Chiao Chang, et al.
Published: (2018) -
Oral mucositis severity in patient with head and neck cancer undergoing chemotherapy and/or radiotherapy
by: Dewi Oktafia Traktama, et al.
Published: (2018-12-01)